In Vitro Metabolism of the Novel, Highly Selective Oral Angiogenesis Inhibitor Motesanib Diphosphate in Preclinical Species and in HumansChun Li, Sekhar Surapaneni, Mike Hayashi et al.|Drug Metabolism and Disposition|2009Cited by 15
Activity-based exposure comparisons among humans and nonclinical safety testing species in an extensively metabolized drug candidateXiaochun Zhu, Raju Subramanian, J. Greg Slatter et al.|Xenobiotica|2012Cited by 5